Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The NCI-MATCH trial: lessons for precision oncology.

Autor: O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA. peter.odwyer@pennmedicine.upenn.edu., Gray RJ; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Li S; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Wang V; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Iafrate AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sklar J; Yale University, New Haven, CT, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Coffey B; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA., Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Hamilton SR; City of Hope National Medical Center, Duarte, CA, USA., Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.

Publikováno v: Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1349-1357. Date of Electronic Publication: 2023 Jun 15.

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.

Autor: Flaherty KT; Massachusetts General Hospital, Boston, MA, USA., Gray R; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Li S; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA., Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Iafrate AJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Sklar J; Yale University, New Haven, CT, USA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Catalano R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Magnan R; ECOG-ACRIN Cancer Research Group, Boston, MA, USA., Kibbe W; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA., Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Alexander B; Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Kumar S; Mayo Clinic, Rochester, MN, USA., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA., Caimi P; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Datta V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX, USA., Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Oct 01; Vol. 112 (10), pp. 1021-1029.

Postnatal psychosocial assessment and clinical decision-making, a descriptive study.

Autor: Sims DJ; Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia., Fowler C; Faculty of Health, Tresillian Chair in Child and Family Health, University of Technology Sydney, Ultimo, NSW, Australia.

Publikováno v: Journal of clinical nursing [J Clin Nurs] 2018 Oct; Vol. 27 (19-20), pp. 3739-3749. Date of Electronic Publication: 2018 Jul 23.